Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01672892 · ClinicalTrials.gov registry record · Phase 3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Phase 3 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 289
- Enrollment target
NCT01672892 is a Phase 3 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 289 participants.
The verdict
NCT01672892, a Phase 3 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 289 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This randomized phase III trial is studying two different methods of radiation and their side effects and comparing how well they work in treating endometrial and cervical cancer after surgery.
Interventions
- RADIATION intensity-modulated radiation therapy
- RADIATION Standard radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2012-11 |
| Est. Completion | 2022-05-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01672892
The ClinicalTrials.gov registry entry for NCT01672892 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which intensity-modulated radiation therapy is the first listed.
NCT01672892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01672892 about?
NCT01672892 is a clinical study titled "Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer". RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This randomized phase III tria...
What is the current status of trial NCT01672892?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 289 participants. The study started on 2012-11. Estimated completion is 2022-05-20.
What interventions are being tested in trial NCT01672892?
The interventions under investigation include: intensity-modulated radiation therapy (RADIATION), Standard radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01672892?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.